Skip to content

HCG Screening Test

by Tago, Inc.

510(k) K830156

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK830156 Date9 Feb 1983ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
JHJ
Device Class
Class II
Regulation
21 CFR Part 862.1155
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 24 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The HCG Screening Test is a device used for the qualitative detection of human chorionic gonadotropin (hCG) in urine samples. This test is designed for screening purposes and utilizes an agglutination method to determine pregnancy status. The device is classified under clinical chemistry applications.

The HCG Screening Test is supplied as a point-of-care testing device and is intended for single-use. It is stored according to manufacturer instructions and has received FDA 510(k) clearance with the product code JHJ. The device is available in various sizes and models as specified by the manufacturer.

Other devices from Tago, Inc.

See all devices from Tago, Inc. →

Questions

AI-generated answers, 24 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the HCG Screening Test used for?

    The HCG Screening Test is designed for the qualitative detection of human chorionic gonadotropin (hCG) in urine samples to determine pregnancy status. It utilizes an agglutination method and is intended for screening purposes in clinical chemistry applications.

  • How is the HCG Screening Test supplied and can it be reused?

    The HCG Screening Test is supplied as a point-of-care testing device and is specifically designed for single-use only. It should not be reused or repurposed after initial use to ensure accurate test results and maintain safety standards.

  • What sizes and models are available for the HCG Screening Test?

    The HCG Screening Test is available in various sizes and models as specified by the manufacturer, Tago, Inc. The specific configurations and options would be detailed in the product documentation provided by the manufacturer.

  • How should the HCG Screening Test be stored?

    The HCG Screening Test should be stored according to the manufacturer's instructions to maintain its integrity and functionality. Proper storage conditions would be outlined in the product documentation provided by Tago, Inc.

  • What is the regulatory status of the HCG Screening Test?

    The HCG Screening Test has received FDA 510(k) clearance with the product code JHJ. It is classified under clinical chemistry applications and is considered substantially equivalent to predicate devices in this category.